Impact of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: Landmark analysis of 10-year data from first-line clinical trials.
Toki Anna Bolt
No relevant relationships to disclose
Claudia Pauligk
No relevant relationships to disclose
Dominique Werner
No relevant relationships to disclose
Ralf Dieter Hofheinz
No relevant relationships to disclose
Frank Mayer
No relevant relationships to disclose
Kim Barbara Luley
No relevant relationships to disclose
Nils Homann
No relevant relationships to disclose
Harald Schmalenberg
No relevant relationships to disclose
Matthias Egger
No relevant relationships to disclose
Salah-Eddin Al-Batran
No relevant relationships to disclose